![](https://www.pymnts.com/wp-content/uploads/2023/05/Shutterstock_1548396338-2.jpg)
The Federal Trade Commission has filed a lawsuit to prevent Amgen’s acquisition of Horizon Therapeutics, citing concerns about potential competition limitations in the pharmaceutical industry.
According to the FTC, the agreement would strengthen Amgen’s dominance over two of Horizon’s popular drugs: Tepezza for thyroid eye disease, and Krystexxa for gout treatment.
The agency stated that Amgen could provide rebates for their current drugs in an effort to encourage insurers and pharmacy benefit managers to prioritize the two Horizon products through cross-market bundling.
The Federal Trade Commission asserted that Amgen, a company based in California, has a record of using its drug portfolio to obtain benefits over potential competitors.
Related: Amgen, Teva Get Can Appeal Sensipar Antitrust Ruling
The FTC received a suit regarding the acquisition and pending merger between Indivior and Opian, which Senator Elizabeth Warren had previously requested the regulator to scrutinize due to concerns about potential price increases.
“Today’s action – the FTC’s first challenge to a pharmaceutical merger in recent memory – sends a clear signal to the market: The FTC won’t hesitate to challenge mergers that enable pharmaceutical conglomerates to entrench their monopolies at the expense of consumers and fair competition,” said Holly Vedova, agency’s bureau of competition director, in a statement.
Featured News
Geradin Partners Expands Paris Office with Key Hire
Aug 30, 2024 by
CPI
Judge Accuses Google of ‘Clear Abuse’ in Antitrust Case Over Deleted Employee Chats
Aug 29, 2024 by
CPI
Hong Kong Cleaning Company Employee Charged in Historic Antitrust Investigation Case
Aug 29, 2024 by
CPI
Inside the Yelp Suit: Allegations of Google’s Abuse of Search Power
Aug 29, 2024 by
CPI
AI Safety Bill Clears Hurdle in California, Heads to Governor’s Desk
Aug 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – State Attorneys General
Aug 22, 2024 by
CPI
CPI Talks… …With Attorney General Phil Weiser
Aug 22, 2024 by
CPI
The Bipartisan Miracle of State Antitrust Enforcement
Aug 22, 2024 by
Gwendolyn J. Lindsay Cooley
Recent Developments in State Antitrust Enforcement: Agriculture and Food Markets
Aug 22, 2024 by
Elizabeth R. Odette
State Attorneys General: Stewards of Consumer Health and Welfare
Aug 22, 2024 by
Brooke Howlett Lovrovich